Pfizer Sees Tax Savings From AstraZeneca Deal

Pfizer's nearly $100 billion offer to buy British rival AstraZeneca, if accepted, would allow the pharmaceutical giant to move its official headquarters overseas, saving it billions in taxes.



from WSJ.com: US Business http://ift.tt/1mTsmqp

via IFTTT